HEE-JIN JANG to Immunotherapy
This is a "connection" page, showing publications HEE-JIN JANG has written about Immunotherapy.
Connection Strength
0.309
-
Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy. J Thorac Cardiovasc Surg. 2025 04; 169(4):1082-1095.e4.
Score: 0.147
-
Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors. J Thorac Cardiovasc Surg. 2020 04; 159(4):1598-1610.e3.
Score: 0.104
-
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors. Cancer Cell. 2024 Jul 08; 42(7):1202-1216.e8.
Score: 0.036
-
Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers. Nat Commun. 2017 10 19; 8(1):1050.
Score: 0.023